Bank Of New York Mellon Corp current report, 09 June 2009

Business Context and Reporting Period

Company: The Bank of New York Mellon Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: June 9, 2009
Event: Approval to repurchase preferred stock issued under the Troubled Asset Relief Program (TARP).

Key Financial Metrics

This filing does not report standard operating financial metrics such as revenue, profit, cash flow, margins, or total debt levels. The specific financial details disclosed relate to a capital transaction:

  • Security Type: Fixed Rate Cumulative Perpetual Preferred Stock, Series B.
  • Shares Involved: 3,000,000 shares.
  • Liquidation Preference: $1,000 per share.
  • Total Value: $3,000,000,000 (3 million shares x $1,000).
  • Original Issuance Date: October 28, 2008.

Material Changes

The primary material change is the regulatory approval received from the United States Department of the Treasury. The Bank is now authorized to repurchase all 3,000,000 shares of Series B Preferred Stock previously sold to the Treasury as part of the Capital Purchase Program. This action represents a reduction in the company's preferred equity obligations to the government.

Guidance, Outlook, and Risks

Management Commentary: The filing incorporates a press release announcing the Treasury's approval but does not provide forward-looking guidance, earnings outlook, or specific risk factors within the text of this 8-K.
Unusual Items: The repurchase of TARP-issued preferred stock is a significant capital event, indicating the company's ability to return to a pre-crisis capital structure regarding this specific government injection.

Investor Verification Checklist

  • Verify the exact repurchase price and any associated redemption premiums or fees not explicitly detailed in this summary.
  • Confirm the timing of the actual cash outflow for the repurchase.
  • Review the full text of the press release (Exhibit 99.1) for any conditions attached to the Treasury's approval.
  • Check subsequent filings for the impact of this transaction on the company's total equity and regulatory capital ratios.